We utilized cBioPortal tool to further investigate the genetic alterations of SKA1/2/3 and their correlations with overall survival (OS), progress-free survival (PFS), and disease-specific survival (DSS) of BC patients. This evidence concerns the gene SKA1 and breast cancer.